Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

NOVOZYMES NORTH AMERICA INC.

Filed by ATLAS CROSSING LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 20, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
e4959cb2-8ba9-4c3f-aa2b-dee757626ed3
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Literal federal measure citations: H.R.4794, S.3172

FOO · Food Industry (safety, labeling, etc.)

Issues related to allowance of dietary supplements in the WIC program. FY27 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.